Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Feb 20;10(82):20130006.
doi: 10.1098/rsif.2013.0006. Print 2013 May 6.

The inverse association of cancer and Alzheimer's: a bioenergetic mechanism

Affiliations

The inverse association of cancer and Alzheimer's: a bioenergetic mechanism

Lloyd A Demetrius et al. J R Soc Interface. .

Abstract

The sporadic forms of cancer and Alzheimer's disease (AD) are both age-related metabolic disorders. However, the molecular mechanisms underlying the two diseases are distinct: cancer is described by essentially limitless replicative potential, whereas neuronal death is a key feature of AD. Studies of the origin of both diseases indicate that their sporadic forms are the result of metabolic dysregulation, and a compensatory increase in energy transduction that is inversely related. In cancer, the compensatory metabolic effect is the upregulation of glycolysis-the Warburg effect; in AD, a bioenergetic model based on the interaction between astrocytes and neurons indicates that the compensatory metabolic alteration is the upregulation of oxidative phosphorylation-an inverse Warburg effect. These two modes of metabolic alteration could contribute to an inverse relation between the incidence of the two diseases. We invoke this bioenergetic mechanism to furnish a molecular basis for an epidemiological observation, namely the incidence of sporadic forms of cancer and AD is inversely related. We furthermore exploit the molecular mechanisms underlying the diseases to propose common therapeutic strategies for cancer and AD based on metabolic intervention.

PubMed Disclaimer

References

    1. Roe CM, Behrens MI, Xiong C, Miller JP, Morris JC. 2005. Alzheimer disease and cancer. Neurology 64, 895–898 10.1212/01.WNL.0000152889.94785.51 (doi:10.1212/01.WNL.0000152889.94785.51) - DOI - PubMed
    1. Warburg O. 1956. Origin of cancer cells. Oncologia 9, 75–83 10.1159/000223920 (doi:10.1159/000223920) - DOI - PubMed
    1. Vander Heiden MG, Cantley LC, Thompson CB. 2009. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029–1033 10.1126/science.1160809 (doi:10.1126/science.1160809) - DOI - PMC - PubMed
    1. Seyfried TN, Shelton LM. 2010. Cancer as a metabolic disease. Nutr. Metab. 7, 7. 10.1186/1743-7075-7-7 (doi:10.1186/1743-7075-7-7) - DOI - PMC - PubMed
    1. Hanahan D, Weinberg RA. 2000. The hallmarks of cancer. Cell 100, 57–70 10.1016/S0092-8674(00)81683-9 (doi:10.1016/S0092-8674(00)81683-9) - DOI - PubMed